SCHEMBL2646152

SCHEMBL2646152

COc1ccc(C(=N)SC)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRSS1 P07477 1/20 0.57
PRSS2 P07478 1/20 0.57
PRSS3 P35030 1/20 0.57
PTGIR P43119 1/20 0.52
SMN1; SMN2 Q16637 3/20 0.50
NPC1 O15118 1/20 0.50
TP53 P04637 1/20 0.50
ALOX15 P16050 1/20 0.50
RAB9A P51151 1/20 0.50
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50
CA1 P00915 7/20 0.48
CA2 P00918 7/20 0.48
PLK1 P53350 1/20 0.48
CA12 O43570 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
CA14 Q9ULX7 1/20 0.48
HDAC3 O15379 1/20 0.47
HDAC4 P56524 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL5431640 0.98 PRSS1 (0.55) PRSS1PRSS2PRSS3PTGIRSMN1; SMN2
SCHEMBL12130260 0.78 ALDH1A1 (0.48) PRSS1PRSS2PRSS3SMN1; SMN2NPC1
SCHEMBL10753412 0.77 PRSS1 (0.61) PRSS1PRSS2PRSS3PTGIRSMN1; SMN2
SCHEMBL5082858 0.77 PRSS1 (0.67) PRSS1PRSS2PRSS3PTGIRSMN1; SMN2
SCHEMBL12127499 0.76 ST14 (0.44) SMN1; SMN2NPC1RAB9AHDAC1ALDH1A1
SCHEMBL4627421 0.76 PLK1 (0.61) SMN1; SMN2NPC1TP53ALOX15RAB9A
Iodide SCHEMBL23068701 0.75 TRPV1 (0.48) SMN1; SMN2NPC1RAB9AHDAC3HDAC4
SCHEMBL12175336 0.75 PRSS1 (0.64) PRSS1PRSS2PRSS3PTGIRSMN1; SMN2
SCHEMBL11121046 0.74 CES2 (0.61) SMN1; SMN2NPC1TP53ALOX15RAB9A
SCHEMBL5192809 0.74 NPC1 (0.50) PRSS1PRSS2PRSS3SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6969716-B2 5-phenyl[1,2,4]triazines as ligands for GABA-A α2/α3 receptors for treating anxiety or depression MERCK SHARP & DOHME LTD. 2005-11-29 US disclosed
US-20040192692-A1 5-Phenyl[1,2,4]triazines as ligands for GABA-A alpha2/alpha3 receptors for treating anxiety or depression MERCK SHARP & DOHME, LTD. (GB) 2004-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192692-A1 5-Phenyl[1,2,4]triazines as ligands for GABA-A alpha2/alpha3 receptors for treating anxiety or depression GABRA1, GABRA5, GABRA2 PRSS1 4495/4885PRSS2 4374/4885PRSS3 4246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.